arrow
返回
G

George Wilding

university of texas health science center at san antonio

81H指数
518论文数
3.3W被引数
收录论文 110
发表时间
Mediator kinase inhibition reverses castration resistance of advanced cancer
err2024-03-28
err4
errOAAI
errLi, Jing; Hilimire, Thomas A.; Liu, Yueying; Wang, Lili; Liang, Jiaxin; Gyorffy, Balazs; Sikirzhytski, Vitali; Ji, Hao; Zhang, Li; Cheng, Chen; Ding, Xiaokai; Kerr, Kendall R.; Dowling, Charles E.; Chumanevich, Alexander A.; Mack, Zachary T.; Schools, Gary P.; Lim, Chang-uk; Ellis, Leigh; Zi, Xiaolin; Porter, Donald C.; Broude, Eugenia V.; McInnes, Campbell; Wilding, George; Lilly, Michael B.; Roninson, Igor B.; Chen, Mengqian
err分享
err收藏
CDK8/19-regulated transcriptional reprogramming: a druggable driver of castration-resistant prostate cancer
err2023-12-01
err0
PREAI
errLi, Jing; Hilimire, Thomas; Liu, Yueying; Wang, Lili; Liang, Jiaxin; Gyorffy, Balazs; Sikitzhytski, Vitali; Ji, Hao; Zhang, Li; Cheng, Chen; Ding, Xiaokai; Kerr, Kendall; Dowling, Charles; Schools, Gary; Lim, Chang-Uk; Braude, Eugenia; Wilding, George; Lilly, Michael; Roninson, Igor; Chen, Mengqian
err分享
err收藏
AI powered-platform to predict gene modifications from prostate and breast cancer whole slide images
err2023-04-04
err0
PREAI
errHuang, Wei; Jain, Parag; Xie, Chensu; Muhammad, Hassan; Basu, Hirak; Wilding, George; Roy, Rajat
err分享
err收藏
Predicting Response of Triple-Negative Breast Cancer to Neoadjuvant Chemotherapy Using a Deep Convolutional Neural Network-Based Artificial Intelligence Tool
err2023-03-01
err7
errOAAI
errKrishnamurthy, Savitri; Jain, Parag; Tripathy, Debu; Basset, Roland; Randhawa, Ramandeep; Muhammad, Hassan; Huang, Wei; Yang, Hua; Kummar, Shivaani; Wilding, George; Roy, Rajat
err分享
err收藏
Predicting response of triple negative breast cancer to neoadjuvant chemotherapy using a deep convolutional neural network-based artificial intelligence tool
err2023-03-01
err0
PREAI
errKrishnamurthy, Savitri; Jain, Parag; Tripathy, Debu; Muhammad, Hassan; Huang, Wei; Yang, Hua; Kummar, Shivaani; Wilding, George; Roy, Rajat; Randhawa, Ramandeep
err分享
err收藏
A Novel Artificial Intelligence-Powered Method for Prediction of Early Recurrence of Prostate Cancer After Prostatectomy and Cancer Drivers
err2022-05-01
err15
errOAAI
errHuang, Wei; Randhawa, Ramandeep; Jain, Parag; Hubbard, Samuel; Eickhoff, Jens; Kummar, Shivaani; Wilding, George; Basu, Hirak; Roy, Rajat
err分享
err收藏
Metabolic switch from glycolysis to oxidative phosphorylation (ox-phos) provides survival advantage to anti-androgen-treated prostate cancer cells and make them vulnerable to mitochondrial metabolism inhibitors IACS-010759 and CB-839
err2020-08-15
err2
PREAI
errBasu, Hirak S.; Wilganowski, Nathaniel; Robertson, Samantha; Ramachandran, Sumankalai; Zurita-Saavedra, Amado; Titus, Mark; Cohen, Evan; Reuben, James; Wilding, George
err分享
err收藏
Small-molecule inhibitors targeting a specific metabolic pathway for precision therapy of advanced castrate-resistant prostate cancer.
err2018-08-14
err0
PREAI
errBasu, Hirak; Wilganowski, Nathaniel; Lieblich, Jessica; Wu, Grace; Fokt, Izabela; Ramachandran, Sumankalai; Yu, Jiaquin; Titus, Mark; Priebe, Waldemar; Beebe, David J.; Wilding, George
err分享
err收藏
A metabolic pathway targeted inhibitor for precision therapy of castrate-resistant prostate cancer
err2018-07-01
err0
PREAI
errBasui, Hirak S.; Wilgonowskii, Nathaniel L.; Lieblichi, Jessica L.; Wui, Grace T.; Fokti, Izabela; Ramachandrani, Sumankalai; Yu, Jiaquin; Titusi, Mark; Priebei, Waldemar; Beebe, David J.; Wildingi, George
err分享
err收藏
Naming disease states for clinical utility in prostate cancer: a rose by any other name might not smell as sweet
err2018-01-01
err7
errOAAI
errArmstrong, A. J.; Antonarakis, E. S.; Taplin, M. -E.; Kelly, W. K.; Beltran, H.; Fizazi, K.; Dahut, W. L.; Shore, N.; Slovin, S.; George, D.; Carducci, M. A.; Corn, P.; Danila, D.; Dreicer, R.; Heath, E.; Rathkopf, D.; Liu, G.; Nanus, D.; Stein, M.; Smith, M. R.; Sternberg, C.; Wilding, G.; Nelson, P. S.; Halabi, S.; Kantoff, P.; Clarke, N. W.; Evans, C. P.; Heidenreich, A.; Mottet, N.; Gleave, M.; Morris, M. J.; Scher, H. I.
err分享
err收藏
Safety of long-term (LT) treatment (tmt) of chemotherapy (chemo)-naive metastatic castration-resistant prostate cancer (mCRPC) patients (pts) with abiraterone acetate plus prednisone (AA plus P) for ≥ 4 years (yrs)
err2016-10-01
err21
errOAAI
errCarles, J.; Davis, I.; De Bono, J. S.; Fizazi, K.; Gerritsen, W.; Rathkopf, D. E.; Ryan, C. J.; Saad, F.; Steuber, T.; Wilding, G.; Park, Y. C.; Charnas, R.; De Porre, P.; Van Poppel, H.
err分享
err收藏
Adjuvant sunitinib or sorafenib for high-risk, non-metastatic renal-cell carcinoma (ECOG-ACRIN E2805): a double-blind, placebo-controlled, randomised, phase 3 trial
errLANCET
IF88.5
err2016-05-01
err496
errOAAI
errHaas, Naomi B.; Manola, Judith; Uzzo, Robert G.; Flaherty, Keith T.; Wood, Christopher G.; Kane, Christopher; Jewett, Michael; Dutcher, Janice P.; Atkins, Michael B.; Pins, Michael; Wilding, George; Cella, David; Wagner, Lynne; Matin, Surena; Kuzel, Timothy M.; Sexton, Wade J.; Wong, Yu-Ning; Choueiri, Toni K.; Pili, Roberto; Puzanov, Igor; Kohli, Manish; Stadler, Walter; Carducci, Michael; Coomes, Robert; DiPaola, Robert S.
err分享
err收藏
Mipsagargin, a novel thapsigargin-based PSMA-activated prodrug: results of a first-in-man phase I clinical trial in patients with refractory, advanced or metastatic solid tumours
err2016-04-26
err140
errOAAI
errMahalingam, D.; Wilding, G.; Denmeade, S.; Sarantopoulas, J.; Cosgrove, D.; Cetnar, J.; Azad, N.; Bruce, J.; Kurman, M.; Allgood, V. E.; Carducci, M.
err分享
err收藏
A multicenter phase 1/2a dose-escalation study of the antioxidant moiety of vitamin E 2,2,5,7,8-pentamethyl-6-chromanol (APC-100) in men with advanced prostate cancer
err2016-02-29
err9
errOAAI
errKyriakopoulos, Christos E.; Heath, Elisabeth I.; Eickhoff, Jens C.; Kolesar, Jill; Yayehyirad, Mulusew; Moll, Thomas; Wilding, George; Liu, Glenn
err分享
err收藏
A phase I study of selumetinib (AZD6244/ARRY-142866), a MEK1/2 inhibitor, in combination with cetuximab in refractory solid tumors and KRAS mutant colorectal cancerMEK1/2抑制剂司美替尼 (AZD6244/ARRY-142866) 与西妥昔单抗联合治疗难治性实体瘤和KRAS突变型结直肠癌的I期研究
err2015-12-14
err49
errOAAI
errDeming, Dustin A.; Cavalcante, Ludmila L.; Lubner, Sam J.; Mulkerin, Daniel L.; LoConte, Noelle K.; Eickhoff, Jens C.; Kolesar, Jill M.; Fioravanti, Suzanne; Greten, Tim F.; Compton, Kathryn; Doyle, Austin G.; Wilding, George; Duffy, Austin; Liu, Glenn
err分享
err收藏
Effect of Renal Impairment on the Pharmacokinetics and Safety of Axitinib
err2015-09-24
err16
errOAAI
errChen, Ying; Rini, Brian I.; Motzer, Robert J.; Dutcher, Janice P.; Rixe, Olivier; Wilding, George; Stadler, Walter M.; Tarazi, Jamal; Garrett, May; Pithavala, Yazdi K.
err分享
err收藏
Effects of Adjuvant Sorafenib and Sunitinib on Cardiac Function in Renal Cell Carcinoma Patients without Overt Metastases: Results from ASSURE, ECOG 2805
err2015-09-14
err49
errOAAI
errHaas, Naomi B.; Manola, Judith; Ky, Bonnie; Flaherty, Keith T.; Uzzo, Robert G.; Kane, Christopher J.; Jewett, Michael; Wood, Lori; Wood, Christopher G.; Atkins, Michael B.; Dutcher, Janice J.; Wilding, George; DiPaola, Robert S.
err分享
err收藏
A National Multicenter Phase 2 Study of Prostate-specific Antigen (PSA) Pox Virus Vaccine with Sequential Androgen Ablation Therapy in Patients with PSA Progression: ECOG 9802
err2015-09-01
err33
errOAAI
errDiPaola, Robert S.; Chen, Yu-Hui; Bubley, Glenn J.; Stein, Mark N.; Hahn, Noah M.; Carducci, Michael A.; Lattime, Edmund C.; Gulley, James L.; Arlen, Philip M.; Butterfield, Lisa H.; Wilding, George
err分享
err收藏
Mitophagy imparts enzalutamide resistance in prostate cancer
err2015-08-01
err2
PREAI
errBasu, Hirak S.; Schrieber, Cynthia L.; Sperger, Jamie M.; Naundorf, Maryanne; Weichman, Ashley M.; Mehraein-Ghomi, Farideh; Church, Dawn R.; Lang, Joshua M.; Wilding, George
err分享
err收藏